| A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations (NCT01290484) | Stanford University | 2010-12-01 |
| Efficacy Study of Two Choices of Phototherapy on Itching Skin Diseases (NCT01254240) | University of Zurich | 2010-12-01 |
| Biological Standardization of Allergen Extracts of Pollens of Betula Pendula, Phleum Pratense and Mite Extract of Dermatophagoides Pteronyssinus (NCT01147159) | Roxall Medicina España S.A | 2010-12-01 |
| Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II Trial (NCT01272557) | PD Dr. med. Matthias Dollinger | 2010-12-01 |
| Bryophyllum Versus Placebo for Overactive Bladder (NCT01127126) | University of Zurich | 2010-12-01 |
| Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer (NCT01267240) | National Cancer Institute (NCI) | 2010-12-01 |
| Clinical Trial Corticoids For Empyema And Pleural Effusion In Children (NCT01261546) | Hospital Infanta Sofia | 2010-12-01 |
| A Study of Fibrocaps in Liver Surgery in the Netherlands (NCT01256190) | Mallinckrodt | 2010-12-01 |
| RAD001 and Intravesical Gemcitabine in BCG-Refractory Primary or Secondary Carcinoma In Situ of the Bladder (NCT01259063) | Memorial Sloan Kettering Cancer Center | 2010-12-01 |
| Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS) (NCT01256489) | Massachusetts Eye and Ear Infirmary | 2010-12-01 |
| Utilizing A Genomic Sig for "BRCAness" to Eval the Efficacy of Satraplatin in Men With Met. Castration Resistant Prostate Ca (NCT01289067) | William K. Oh | 2010-12-01 |
| A Study to Assess the Efficacy and Safety of ETC-1002 in Subjects With Elevated Blood Cholesterol and Either Normal or Elevated Triglycerides (NCT01262638) | Esperion Therapeutics, Inc. | 2010-12-01 |
| Clinical Trial of Phenylbutyrate and Vitamin D in Tuberculosis (TB) (NCT01580007) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2010-12-01 |
| Phase 1 and Phase 2 Clinical Trials of SNUBH-NM-333(18F) (NCT02149017) | Seoul National University Hospital | 2010-12-01 |
| Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza (NCT01052480) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-12-01 |
| Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme (NCT01285414) | Myrexis Inc. | 2010-12-01 |
| Early Short-term Antibiotic Therapy in Penetrating Abdominal Trauma, 3 vs 7 Days (NCT01203046) | Silvia M. Pinango L. | 2010-12-01 |
| Comparison of Different Up-dosing Schedules With Osiris (NCT01240954) | ALK-Abelló A/S | 2010-12-01 |
| Selumetinib in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (NCT01278615) | National Cancer Institute (NCI) | 2010-12-01 |
| A Study of Pazopanib With CAPEOX in AGC Patients (NCT01130805) | Samsung Medical Center | 2010-12-01 |
| Study of FX005 for the Treatment of Pain in Patients With Osteoarthritis of the Knee (NCT01291914) | Pacira Pharmaceuticals, Inc | 2010-12-01 |
| MTD Study PXD-101 in Combination With Paclitaxel + Carboplatin in Chemotherapy-Naive Patients With Stage IV NSCLC (NCT01310244) | Acrotech Biopharma Inc. | 2010-12-01 |
| Weekly Paclitaxel With or Without Pazopanib in Platinum Resistant or Refractory Ovarian Cancer (NCT01644825) | National Cancer Institute, Naples | 2010-12-01 |
| Cognitive Stimulation (NCT01271413) | Johns Hopkins University | 2010-12-01 |
| Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis Fungoides (NCT01187446) | Stanford University | 2010-12-01 |
| Edessy ICSI Outcome Embryo Score (EIOS) Efficacy (NCT02082288) | Al-Azhar University | 2010-12-01 |
| Effects of Balance Training in Older Adults With Dementia (NCT02073318) | National Taiwan University Hospital | 2010-12-01 |
| Gefitinib Combined With Radiotherapy in Elderly Patients With Esophageal Cancer (NCT01291823) | Zhejiang Cancer Hospital | 2010-12-01 |
| Eribulin With Trastuzumab as First-line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer (NCT01269346) | Eisai Inc. | 2010-12-01 |
| Apotransferrin in Atransferrinemia (NCT01797055) | Prothya Biosolutions | 2010-12-01 |
| Effect of Pterostilbene on Cholesterol, Blood Pressure and Oxidative Stress (NCT01267227) | University of Mississippi Medical Center | 2010-12-01 |
| Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma (NCT01200342) | M.D. Anderson Cancer Center | 2010-12-01 |
| Cetuximab Standard or Dose Escalation in First Line Colorectal Cancer (NCT01251536) | Universitaire Ziekenhuizen KU Leuven | 2010-12-01 |
| Topical "Non-Aromatic Very Rich in Steranes" (NAVS) Naphthalan for the Treatment of Oral Mucosal Diseases (NCT02920658) | Ivan Alajbeg | 2010-12-01 |
| PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer (NCT01227018) | Vanderbilt-Ingram Cancer Center | 2010-12-01 |
| Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab (NCT01442649) | UNICANCER | 2010-12-01 |
| Study of Sorafenib With or Without VT-122 in Patients With Hepatocellular Carcinoma (HCC) (NCT01265576) | Vicus Therapeutics | 2010-12-01 |
| Randomized Study of PH-10 for Psoriasis (NCT01247818) | Provectus Pharmaceuticals | 2010-12-01 |
| Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant (NCT01118013) | Alliance for Clinical Trials in Oncology | 2010-12-01 |
| Therapy Trial to Determine the Safety and Efficacy of Heavy Ion Radiotherapy in Patients With Osteosarcoma (NCT01005043) | University Hospital Heidelberg | 2010-12-01 |
| Lenalidomide in Treating Patients With High-Risk Chronic Lymphocytic Leukemia (NCT01271283) | National Cancer Institute (NCI) | 2010-12-01 |
| Computerized Mobilization of the Cervical Spine Utilizing the Occiflex Device for the Treatment of Chronic Neck Pain (NCT01216566) | Hillel Yaffe Medical Center | 2010-12-01 |
| Study of Alternative Vaccination Schedule of Oral Cholera Vaccine (NCT01233362) | International Vaccine Institute | 2010-12-01 |
| Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A (NCT01401257) | Pharnext S.C.A. | 2010-12-01 |
| Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib) (NCT01880515) | Instituto Nacional de Cancerologia de Mexico | 2010-12-01 |
| Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy (NCT01222767) | PharmaMar | 2010-12-01 |
| Tissue Distribution of F18-FDG Labelled Autologous Bone Marrow Derived Stem Cells in Patients With Type 2 DM (NCT01694173) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2010-12-01 |
| Interventional Study in Adults With Immune Thrombocytopenia Purpura (ITP) Receiving Romiplostim (NCT01143038) | Amgen | 2010-11-30 |
| F-18 Sodium Fluoride in Prostate Cancer (NCT01240551) | National Cancer Institute (NCI) | 2010-11-30 |
| A Study of Ixazomib Administered in Combination With Lenalidomide and Low-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma (NCT01217957) | Millennium Pharmaceuticals, Inc. | 2010-11-22 |
| Investigating Re-Dosing With Otelixizumab in Adults With Newly-Diagnosed Type 1 Diabetes Mellitus (NCT01222078) | GlaxoSmithKline | 2010-11-22 |
| A Study of RO5185426 in Previously Treated Melanoma Patients With Brain Metastases (NCT01253564) | Hoffmann-La Roche | 2010-11-22 |
| Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors (NCT01217437) | National Cancer Institute (NCI) | 2010-11-22 |
| A Pilot Clinical Trial of Exendin-4 in Alzheimer's Disease (NCT01255163) | National Institute on Aging (NIA) | 2010-11-21 |
| Dose-finding Study of GSK2248761 in Antiretroviral Therapy-Naive Subjects (SIGNET) (NCT01231555) | ViiV Healthcare | 2010-11-18 |
| Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma (NCT00972478) | National Cancer Institute (NCI) | 2010-11-15 |
| Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer (NCT01245712) | M.D. Anderson Cancer Center | 2010-11-15 |
| Using Sorafenib as a Salvage Treatment for Relapsed or Refractory Acute Myeloid Leukemia Carrying FLT3-ITD (NCT03622541) | The University of Hong Kong | 2010-11-15 |
| Study Comparing Three Doses of MDMA Along With Therapy in Veterans With Posttraumatic Stress Disorder (NCT01211405) | Resilient Pharmaceuticals | 2010-11-10 |
| CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer (NCT01218867) | National Cancer Institute (NCI) | 2010-11-10 |
| Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia A (NCT01178294) | Baxalta now part of Shire | 2010-11-10 |
| Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma (NCT01239368) | National Cancer Institute (NCI) | 2010-11-10 |
| A Study in Subjects With Recurrent Malignant Glioma (NCT01137604) | Eisai Inc. | 2010-11-09 |
| Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's Disease (NCT01150890) | Amgen | 2010-11-09 |
| Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells (NCT01097057) | Fred Hutchinson Cancer Center | 2010-11-09 |
| Efficacy and Safety of GSK Biologicals HIV Vaccine in Antiretroviral Therapy (ART)-naïve HIV-1 Infected Persons (NCT01218113) | GlaxoSmithKline | 2010-11-08 |
| Study Assessing Potential Predictive Tumor Markers in Metastatic Colorectal Cancer (NCT01288339) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2010-11-08 |
| High-Dose Gemcitabine, Busulfan and Melphalan With Hematopoietic-Cell Support for Patients With Poor-Risk Myeloma (NCT01237951) | M.D. Anderson Cancer Center | 2010-11-08 |
| Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer (NCT01413750) | National Cancer Institute (NCI) | 2010-11-08 |
| Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-centre, Dose Ranging Study to Evaluate the Efficacy and Safety of Losmapimod Tablets Administered Twice Daily Compared With Placebo for 24 Weeks in Adult Subjects With Chronic Obstructive Pulmonary Disease (COPD). (NCT01218126) | GlaxoSmithKline | 2010-11-04 |
| Metabolic Effects of Non-Nutritive Sweeteners (NCT01200940) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2010-11-04 |
| A Pivotal Study to Assess the Effectiveness of Nasal Dilator (Breathe Right Nasal Strips) (NCT03549130) | GlaxoSmithKline | 2010-11-04 |
| Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL) (NCT01168921) | M.D. Anderson Cancer Center | 2010-11-03 |
| GSK1120212 Rollover Study (NCT01376310) | Novartis Pharmaceuticals | 2010-11-02 |
| CAPOX in KRAS Wild-Type Advanced Adenocarcinoma of the Small Bowel or Ampulla of Vater (NCT01202409) | M.D. Anderson Cancer Center | 2010-11-02 |
| A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer Patients (NCT01284920) | Astellas Pharma Inc | 2010-11-02 |
| Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer (NCT01240629) | University of Southern California | 2010-11-02 |
| Natalizumab (BG00002, Tysabri) Study in Japanese Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) (NCT01440101) | Biogen | 2010-11-01 |
| Trastuzumab and Vinorelbine in Advanced Breast Cancer (NCT01185509) | Dana-Farber Cancer Institute | 2010-11-01 |
| Management of Endometrial Hyperplasia With a LNG-IUS: Multicenter Study: KGOG2006 (NCT01234818) | Korean Gynecologic Oncology Group | 2010-11-01 |
| Prediction of the Effectiveness of Hypofractionated Radiation Therapy in Early Stage Lung Cancer by Bio-imaging and Biomarkers (NCT01138748) | University Hospital, Ghent | 2010-11-01 |
| First Autologous Transplant on Minimal Residual Disease Markers in Previously Untreated Myeloma Undergoing Initial Treatment With Velcade (NCT01215344) | Vanderbilt-Ingram Cancer Center | 2010-11-01 |
| Nilotinib for Cytomegalovirus Prophylaxis and Treatment After Allogeneic Hematopoietic Stem Cell Transplantation (NCT01252017) | National Taiwan University Hospital | 2010-11-01 |
| Efficacy, Safety, and Pharmacokinetics of QAW039 (NCT01253603) | Novartis Pharmaceuticals | 2010-11-01 |
| The Qutenza Patch as Treatment for Disabling Treprostinil (Remodulin) Infusion Site Pain (NCT01260454) | University of Rochester | 2010-11-01 |
| A Device Designed to Protect the Perineum During Labor (NCT01533467) | Helsingborgs Hospital | 2010-11-01 |
| Early Bactericidal Activity (EBA) of SQ109 in Adult Subjects With Pulmonary TB (NCT01218217) | Michael Hoelscher | 2010-11-01 |
| A Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapy (NCT01234519) | AEterna Zentaris | 2010-11-01 |
| Efficacy of TPI ASM8 During a 14-Day Allergen Challenge (NCT01158898) | Syntara | 2010-11-01 |
| Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer (NCT01256762) | Geron Corporation | 2010-11-01 |
| Extension Study Evaluating the Long Term Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET) (NCT01236638) | Sierra Oncology LLC - a GSK company | 2010-11-01 |
| Safety Study of High-Dose Ranibizumab for Polypoidal Choroidal Vasculopathy (NCT01248117) | Retina Consultants of Hawaii | 2010-11-01 |
| Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Docetaxel and Prednisone (CRPC) (NCT01234025) | Ionis Pharmaceuticals, Inc. | 2010-11-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MDCO-2010 in Patients Undergoing Elective Coronary Artery Bypass Graft Surgery (NCT01535222) | The Medicines Company | 2010-11-01 |
| Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD) (NCT01060878) | Phytopharm | 2010-11-01 |
| The Effects of a Regenerative Mitochondrial Medication on Physiological Parameters in Case of Diabetes Mellitus Type II (NCT01197092) | Center for Integrative Medicine, Germany | 2010-11-01 |
| A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension (NCT01256411) | Novartis Pharmaceuticals | 2010-11-01 |
| Simvastatin + Cetuximab/Irinotecan in K-ras Mutant Colorectal Cancer (CRC) (NCT01281761) | Samsung Medical Center | 2010-11-01 |
| Clinical Effects of Tooth Powder on Gingivitis (NCT01902095) | Sheikh Zayed Federal Postgraduate Medical Institute | 2010-11-01 |
| Multicenter Clinical Efficacy and Safety Study of Delayed Release 6MP in Crohn's Disease (NCT01094613) | Teva GTC | 2010-11-01 |